Great News

Clarivate today has just published the new edition of the Journal Citation Report: Reumatismo achieved an initial impact factor of 1.4! In the Clarivate’s “RHEUMATOLOGY" category, Reumatismo ranks 45/54, Q4.  

We would like to express our gratitude to everyone who contributed to the journal. Their continued trust and engagement have motivated us to strive for excellence and continue pushing the boundaries of research.

As we celebrate this remarkable accomplishment, we remain committed to upholding the highest standards of academic publishing. We will continue to provide a platform for groundbreaking research and foster an environment that promotes collaboration and innovation. Together, we will continue to make significant contributions to the advancement of knowledge and the progress of our fields.

We look forward to sharing more exciting developments and groundbreaking research with our audience in the future.